LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 10 of total 190

Search options

  1. Article: Targeting Cysteine Oxidation in Thrombotic Disorders.

    Yang, Moua / Silverstein, Roy L

    Antioxidants (Basel, Switzerland)

    2024  Volume 13, Issue 1

    Abstract: Oxidative stress increases the risk for clinically significant thrombotic events, yet the mechanisms by which oxidants become prothrombotic are unclear. In this review, we provide an overview of cysteine reactivity and oxidation. We then highlight recent ...

    Abstract Oxidative stress increases the risk for clinically significant thrombotic events, yet the mechanisms by which oxidants become prothrombotic are unclear. In this review, we provide an overview of cysteine reactivity and oxidation. We then highlight recent findings on cysteine oxidation events in oxidative stress-related thrombosis. Special emphasis is on the signaling pathway induced by a platelet membrane protein, CD36, in dyslipidemia, and by protein disulfide isomerase (PDI), a member of the thiol oxidoreductase family of proteins. Antioxidative and chemical biology approaches to target cysteine are discussed. Lastly, the knowledge gaps in the field are highlighted as they relate to understanding how oxidative cysteine modification might be targeted to limit thrombosis.
    Language English
    Publishing date 2024-01-09
    Publishing country Switzerland
    Document type Journal Article ; Review
    ZDB-ID 2704216-9
    ISSN 2076-3921
    ISSN 2076-3921
    DOI 10.3390/antiox13010083
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article ; Online: PCSK9 (Proprotein Convertase Subtilisin/Kexin 9) Goes "DAMP".

    Silverstein, Roy L

    Circulation

    2020  Volume 143, Issue 1, Page(s) 62–64

    MeSH term(s) Cholesterol, LDL ; Humans ; Proprotein Convertase 9/genetics ; Subtilisins
    Chemical Substances Cholesterol, LDL ; PCSK9 protein, human (EC 3.4.21.-) ; Proprotein Convertase 9 (EC 3.4.21.-) ; Subtilisins (EC 3.4.21.-)
    Language English
    Publishing date 2020-12-30
    Publishing country United States
    Document type Editorial ; Comment
    ZDB-ID 80099-5
    ISSN 1524-4539 ; 0009-7322 ; 0069-4193 ; 0065-8499
    ISSN (online) 1524-4539
    ISSN 0009-7322 ; 0069-4193 ; 0065-8499
    DOI 10.1161/CIRCULATIONAHA.120.051940
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  3. Article ; Online: Linking Metabolic Dysfunction to Atherosclerosis Via Activation of Macrophage CD36 Gene Transcription by Retinol Binding Protein-4.

    Silverstein, Roy L

    Circulation

    2017  Volume 135, Issue 14, Page(s) 1355–1356

    MeSH term(s) Atherosclerosis ; CD36 Antigens/genetics ; Cholesterol ; Foam Cells ; Humans ; Lipoproteins, LDL ; Macrophages ; Transcription, Genetic
    Chemical Substances CD36 Antigens ; Lipoproteins, LDL ; Cholesterol (97C5T2UQ7J)
    Language English
    Publishing date 2017-03-23
    Publishing country United States
    Document type Editorial ; Research Support, N.I.H., Extramural ; Comment
    ZDB-ID 80099-5
    ISSN 1524-4539 ; 0009-7322 ; 0069-4193 ; 0065-8499
    ISSN (online) 1524-4539
    ISSN 0009-7322 ; 0069-4193 ; 0065-8499
    DOI 10.1161/CIRCULATIONAHA.117.027505
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  4. Article ; Online: Oxidized Lipid Uptake by Scavenger Receptor CD36 (Cluster of Differentiation 36) Modulates Endothelial Surface Properties and May Contribute to Atherogenesis.

    Silverstein, Roy L

    Arteriosclerosis, thrombosis, and vascular biology

    2017  Volume 38, Issue 1, Page(s) 4–5

    MeSH term(s) Atherosclerosis ; CD36 Antigens ; Humans ; Lipoproteins, LDL ; Receptors, Scavenger ; Surface Properties
    Chemical Substances CD36 Antigens ; Lipoproteins, LDL ; Receptors, Scavenger
    Language English
    Publishing date 2017-12-28
    Publishing country United States
    Document type Editorial ; Research Support, N.I.H., Extramural ; Comment
    ZDB-ID 1221433-4
    ISSN 1524-4636 ; 1079-5642
    ISSN (online) 1524-4636
    ISSN 1079-5642
    DOI 10.1161/ATVBAHA.117.310351
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  5. Article ; Online: Metabolic Manipulation to Put the Brakes on Platelet Activation: A Potential Novel Pharmacologic Approach to Atherothrombosis.

    Silverstein, Roy L

    Arteriosclerosis, thrombosis, and vascular biology

    2016  Volume 36, Issue 10, Page(s) 2031–2032

    MeSH term(s) Blood Platelets ; Humans ; Platelet Activation/drug effects ; Platelet Aggregation Inhibitors ; Thrombosis
    Chemical Substances Platelet Aggregation Inhibitors
    Language English
    Publishing date 2016-11-14
    Publishing country United States
    Document type Editorial ; Comment
    ZDB-ID 1221433-4
    ISSN 1524-4636 ; 1079-5642
    ISSN (online) 1524-4636
    ISSN 1079-5642
    DOI 10.1161/ATVBAHA.116.308218
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  6. Article ; Online: CD36, a signaling receptor and fatty acid transporter that regulates immune cell metabolism and fate.

    Chen, Yiliang / Zhang, Jue / Cui, Weiguo / Silverstein, Roy L

    The Journal of experimental medicine

    2022  Volume 219, Issue 6

    Abstract: CD36 is a type 2 cell surface scavenger receptor widely expressed in many immune and non-immune cells. It functions as both a signaling receptor responding to DAMPs and PAMPs, as well as a long chain free fatty acid transporter. Recent studies have ... ...

    Abstract CD36 is a type 2 cell surface scavenger receptor widely expressed in many immune and non-immune cells. It functions as both a signaling receptor responding to DAMPs and PAMPs, as well as a long chain free fatty acid transporter. Recent studies have indicated that CD36 can integrate cell signaling and metabolic pathways through its dual functions and thereby influence immune cell differentiation and activation, and ultimately help determine cell fate. Its expression along with its dual functions in both innate and adaptive immune cells contribute to pathogenesis of common diseases, including atherosclerosis and tumor progression, which makes CD36 and its downstream effectors potential therapeutic targets. This review comprehensively examines the dual functions of CD36 in a variety of immune cells, especially macrophages and T cells. We also briefly discuss CD36 function in non-immune cells, such as adipocytes and platelets, which impact the immune system via intercellular communication. Finally, outstanding questions in this field are provided for potential directions of future studies.
    MeSH term(s) Atherosclerosis/metabolism ; CD36 Antigens/metabolism ; Fatty Acids/metabolism ; Humans ; Macrophages/metabolism ; Membrane Transport Proteins/metabolism ; Signal Transduction
    Chemical Substances CD36 Antigens ; CD36 protein, human ; Fatty Acids ; Membrane Transport Proteins
    Language English
    Publishing date 2022-04-19
    Publishing country United States
    Document type Journal Article ; Review ; Research Support, N.I.H., Extramural ; Research Support, Non-U.S. Gov't
    ZDB-ID 218343-2
    ISSN 1540-9538 ; 0022-1007
    ISSN (online) 1540-9538
    ISSN 0022-1007
    DOI 10.1084/jem.20211314
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  7. Article ; Online: Disabling the platelet's brakes to promote thrombosis.

    Silverstein, Roy L

    Blood

    2015  Volume 125, Issue 17, Page(s) 2591–2593

    Abstract: In this issue of Blood, Magwenzi et al from the University of Hull report a novel mechanistic connection between oxidized low-density lipoprotein (oxLDL)-induced prothrombotic platelet signaling and the inhibition of endogenous platelet anti-activating ... ...

    Abstract In this issue of Blood, Magwenzi et al from the University of Hull report a novel mechanistic connection between oxidized low-density lipoprotein (oxLDL)-induced prothrombotic platelet signaling and the inhibition of endogenous platelet anti-activating signaling mediated by the nitric oxide (NO)/guanosine 3′,5′-cyclic monophosphate (cGMP)/protein kinase G (PKG) pathway.
    MeSH term(s) Animals ; Blood Platelets/cytology ; CD36 Antigens/metabolism ; Cyclic GMP-Dependent Protein Kinases/metabolism ; Humans ; Lipoproteins, LDL/metabolism ; Membrane Glycoproteins/metabolism ; NADPH Oxidases/metabolism ; Signal Transduction
    Chemical Substances CD36 Antigens ; Lipoproteins, LDL ; Membrane Glycoproteins ; NADPH Oxidases (EC 1.6.3.-) ; Cyclic GMP-Dependent Protein Kinases (EC 2.7.11.12)
    Language English
    Publishing date 2015-04-22
    Publishing country United States
    Document type Journal Article ; Comment
    ZDB-ID 80069-7
    ISSN 1528-0020 ; 0006-4971
    ISSN (online) 1528-0020
    ISSN 0006-4971
    DOI 10.1182/blood-2015-03-630822
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  8. Article ; Online: CD36 signaling in vascular redox stress.

    Yang, Moua / Silverstein, Roy L

    Free radical biology & medicine

    2019  Volume 136, Page(s) 159–171

    Abstract: Scavenger receptor CD36 is a multifunctional membrane protein that promotes thrombosis in conditions of oxidative stress such as metabolic disorders including dyslipidemia, diabetes mellitus, and chronic inflammation. In these conditions, specific ... ...

    Abstract Scavenger receptor CD36 is a multifunctional membrane protein that promotes thrombosis in conditions of oxidative stress such as metabolic disorders including dyslipidemia, diabetes mellitus, and chronic inflammation. In these conditions, specific reactive oxidant species are generated that are context and cell dependent. In the vasculature, CD36 signaling in smooth muscle cells and endothelial cells promotes generation of reactive oxygen species, genetic downregulation of antioxidant genes, and impaired smooth muscle and endothelial function. In hematopoietic cells, CD36 signaling enhances platelet dysfunction thus decreasing the threshold for platelet activation and accelerating arterial thrombosis, whereas in macrophages, CD36 promotes lipid-laden foam cell formation and atherosclerosis. These clinically significant processes are mediated through complex redox regulated signaling mechanisms that include Src-family kinases, MAP kinases and other downstream effectors. We provide an overview of CD36 signaling in vascular redox stress highlighting the role in oxidant generation in vascular and hematopoietic cells, but with special emphasis on platelets and dyslipidemia.
    MeSH term(s) Animals ; Blood Platelets/metabolism ; CD36 Antigens/metabolism ; Dyslipidemias/metabolism ; Endothelial Cells/metabolism ; Humans ; Oxidation-Reduction ; Oxidative Stress/physiology ; Platelet Activation/physiology ; Signal Transduction/physiology
    Chemical Substances CD36 Antigens
    Language English
    Publishing date 2019-02-27
    Publishing country United States
    Document type Journal Article ; Research Support, N.I.H., Extramural ; Research Support, Non-U.S. Gov't ; Review
    ZDB-ID 807032-5
    ISSN 1873-4596 ; 0891-5849
    ISSN (online) 1873-4596
    ISSN 0891-5849
    DOI 10.1016/j.freeradbiomed.2019.02.021
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  9. Article ; Online: Platelet metabolism meets thrombosis.

    Chen, Yiliang / Silverstein, Roy L

    Blood

    2018  Volume 132, Issue 11, Page(s) 1089–1091

    MeSH term(s) AMP-Activated Protein Kinases ; Blood Platelets ; Humans ; Phospholipids ; Platelet Function Tests ; Thrombosis
    Chemical Substances Phospholipids ; AMP-Activated Protein Kinases (EC 2.7.11.31)
    Language English
    Publishing date 2018-09-12
    Publishing country United States
    Document type Journal Article ; Comment
    ZDB-ID 80069-7
    ISSN 1528-0020 ; 0006-4971
    ISSN (online) 1528-0020
    ISSN 0006-4971
    DOI 10.1182/blood-2018-08-865600
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  10. Article ; Online: CD36 and ERK5 link dyslipidemia to apoptotic-like platelet procoagulant function.

    Yang, Moua / Silverstein, Roy L

    Current opinion in hematology

    2019  Volume 26, Issue 5, Page(s) 357–365

    Abstract: Purpose of review: Metabolic diseases, including dyslipidemia, diabetes mellitus, and chronic inflammation are risk factors for clinically significant thrombotic events. Thrombosis in these settings is multifaceted with coordinated mechanisms between ... ...

    Abstract Purpose of review: Metabolic diseases, including dyslipidemia, diabetes mellitus, and chronic inflammation are risk factors for clinically significant thrombotic events. Thrombosis in these settings is multifaceted with coordinated mechanisms between platelet activation and the hemostatic pathways. This review focuses on recent advances in platelet procoagulant and apoptotic signaling with emphasis on the pathophysiologic mechanisms induced by platelet CD36 in dyslipidemia, and the key unaddressed questions relating to the field.
    Recent findings: CD36 promotes platelet activation and increases the risk for thrombosis through signaling events. These include generation of reactive oxygen species, activation of redox-sensitive MAP kinase ERK5, and promotion of a pro-thrombotic phenotype. CD36 promotes phosphatidylserine externalization leading to a procoagulant function downstream from MAP kinase ERK5 that is separate from a pro-aggregatory function. Phosphatidylserine externalization requires maladaptive caspase activation, promotes assembly of the factor tenase and prothrombinase complex, and promotes fibrin formation. It is distinct from the canonical pathways mediating platelet procoagulant function by strong physiologic stimuli or by the platelet apoptotic-like Bak/Bax-mediated pathway for cellular clearance.
    Summary: Understanding CD36 signaling in the context of dyslipidemia, or other metabolic diseases will identify important and novel signaling hubs that could be potential therapeutic targets for intervention without impacting hemostasis.
    MeSH term(s) Apoptosis ; Blood Coagulation ; CD36 Antigens/genetics ; CD36 Antigens/metabolism ; Dyslipidemias/metabolism ; Humans ; Mitogen-Activated Protein Kinase 7/genetics ; Mitogen-Activated Protein Kinase 7/metabolism ; Platelet Activation ; Signal Transduction ; bcl-2 Homologous Antagonist-Killer Protein/metabolism ; bcl-2-Associated X Protein/metabolism
    Chemical Substances BAK1 protein, human ; BAX protein, human ; CD36 Antigens ; CD36 protein, human ; bcl-2 Homologous Antagonist-Killer Protein ; bcl-2-Associated X Protein ; MAPK7 protein, human (EC 2.7.11.24) ; Mitogen-Activated Protein Kinase 7 (EC 2.7.11.24)
    Language English
    Publishing date 2019-06-29
    Publishing country United States
    Document type Journal Article ; Research Support, N.I.H., Extramural ; Research Support, Non-U.S. Gov't ; Review
    ZDB-ID 1153887-9
    ISSN 1531-7048 ; 1065-6251
    ISSN (online) 1531-7048
    ISSN 1065-6251
    DOI 10.1097/MOH.0000000000000522
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

To top